Investigating how IL-33 and ST2 control inflammation and fibrosis

On- and Off-Axis Control of Fibrosis by IL-33 and ST2

NIH-funded research Baltimore VA Medical Center · NIH-10951496

This study is looking at how a protein called IL-33 and its receptor ST2 can help manage inflammation and scarring in different diseases, with the hope of finding new ways to treat these conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBaltimore VA Medical Center NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-10951496 on NIH RePORTER

What this research studies

This research focuses on the roles of Interleukin-33 (IL-33) and its receptor ST2 in managing various inflammatory and fibrotic diseases. It examines both the mature form of IL-33 and its full-length precursor to understand their distinct effects on inflammation and fibrosis. The study aims to uncover how these molecules interact and influence immune responses, potentially leading to new therapeutic strategies. By exploring both 'on-axis' and 'off-axis' pathways, the research seeks to clarify the mechanisms behind these conditions and identify new targets for treatment.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with inflammatory or fibrotic conditions, such as asthma, allergies, or other related diseases.

Not a fit: Patients with non-inflammatory conditions or those not affected by fibrosis may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for patients suffering from inflammatory and fibrotic diseases.

How similar studies have performed: Previous research has shown promising results in understanding the roles of IL-33 and ST2 in inflammation, suggesting that this approach could yield valuable insights.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.